|
Error creating thumbnail |
This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
Powershares Dynamic Pharmaceuticals Portfolio ETF (PJP)
The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceuticals Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. [1]
Holdings | % of Portfolio |
Abbott Laboratories | 5.54% |
Bristol-Myers Squibb Co. | 5.23% |
Eli Lilly & Co. | 5.10% |
Pfizer Inc. | 5.09% |
Merck & Co Inc | 5.06% |
Gilead Sciences Inc. | 5.01% |
Johnson & Johnson | 4.92% |
Amgen Inc. | 4.50% |
Impax Laboratories Inc. | 3.85% |
Valeant Pharmaceuticals International | 3.49% |
Holdings as of 17/11/2009
ETF Name | Fund Manager | Expense Ratio |
iShares Dow Jones U.S. Pharmaceuticals Index Fund (IHE) | ishares | 0.48% |
Powershares Dynamic Pharmaceuticals Portfolio ETF (PJP) | Invesco PowerShares | 0.60% |